Has Valerie Glass received payments from drug or device companies?

Yes. Drug and device makers reported $4,525 in general payments to Valerie Glass across 228 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Valerie Glass did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Valerie Glass come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Valerie Glass

Psychiatric/Mental Health · Charlotte, NCNPI 1770719817

Payments from drug & device makers

$4,525in general payments, 2019–2025

Across 228 payments — averaging $19.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$642
AbbVie$598
Supernus Pharmaceuticals, Inc.$555
Otsuka America Pharmaceutical, Inc.$514
Takeda Pharmaceuticals U.S.A., Inc.$269
Tris Pharma Inc$245
plus $2K from 20 others

What the payments were for

Food & beverage$4,515100%
Education$100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	33	$642
AbbVie	29	$598
Supernus Pharmaceuticals, Inc.	29	$555
Otsuka America Pharmaceutical, Inc.	26	$514
Takeda Pharmaceuticals U.S.A., Inc.	15	$269
Tris Pharma Inc	12	$245
Johnson & Johnson	9	$194
Axsome Therapeutics, Inc.	8	$174
Neurocrine Biosciences, Inc.	9	$174
Alkermes, Inc.	7	$170
Vanda Pharmaceuticals Inc.	6	$139
Neos Therapeutics, LP	7	$134
Corium, LLC	5	$114
Bausch Health US, LLC	7	$100
Lundbeck LLC	4	$77
Collegium Pharmaceutical, Inc.	3	$70
Idorsia Pharmaceuticals US Inc	3	$62
Almatica Pharma LLC	3	$58
E.r. Squibb & Sons, L.L.C.	2	$46
Noven Therapeutics, LLC	3	$45
Teva Pharmaceuticals USA, Inc.	2	$34
Vertical Pharmaceuticals, LLC	2	$32
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$29
Brainsway USA Inc	1	$18
Avanir Pharmaceuticals, Inc.	1	$16
Eisai Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VRAYLAR$113

How this compares

$4,525 in reported general payments places this provider in the 90th percentile of 947 psychiatric/mental health providers in North Carolina.

See all psychiatric/mental health providers in North Carolina →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Quetiapine Fumarate ErQuetiapine Fumarate	11	$791
Bupropion XlBupropion Hcl	16	$596
Alprazolam	22	$122

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Charlotte

Desiree MatthewsCharlotte$807K
Benedetto PalomboCharlotte$671K
Carol Cameron MatthewsCharlotte$12K
Rohan MatthewsCharlotte$8K
Carli GastleyCharlotte$8K
Clarence RunnelsCreedmoor$339K
Lisa SuddrethGastonia$111K
April NandigamGreensboro$88K
Hannah NealeyFuquay Varina$75K
Jessica StoneRocky Mount$63K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →